Daniel Bessesen, chief endocrinologist at the University of Colorado School of Medicine, May 6, 2026 Biomolecules, Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss, March 13, 2025 BMJ, Weight regain after cessation of medication for weight management: systematic review and meta-analysis, Jan
The American Journal of Case Reports
Whether you take semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), knowing the TSA rules and how to keep your pen at the right temperature will help your trip go smoothly
Beyond danuglipron, we have early-stage candidates including our oral small molecule GIPR antagonist, which is in Phase II and has the potential to be used in combinations to drive weight loss, they told Tides Global
To access the behaviors outside the habit horizon we must expand motivation and self-efficacy, so the circle itself gets wider